What inspectors are really looking for

Inspectors expect proof, not promises. Stay inspection ready with continuous monitoring.

Your team knows the rules. You understand ALCOA+, 21 CFR Part 11, and what an inspection agenda looks like.

But when the inspector sits down, one question decides how the day goes: can you demonstrate control, not just describe it?

Knowing the rules and proving control are two different things. Closing that gap is where Compliance Builder comes in, and it’s the gap this post is about.

Baseline vs. proof

Most quality teams could recite ALCOA+ in their sleep. Far fewer can produce, on demand, the evidence that shows every principle holding up across every system in the lab.

That distinction, between understanding the standard and demonstrating it, is what separates a smooth inspection from one that generates Form 483 observations and CAPAs. Inspectors aren’t grading your knowledge of the rules. They’re grading your evidence.

ALCOA+ in practice

ALCOA+ data integrity gives inspectors a shared checklist for what “in control” actually looks like. Each principle translates into something concrete they’ll ask you to show:

  • Attributable. Every action tied to a named, identifiable person, not a shared or generic login.
  • Legible. Records that are readable and unambiguous, now and years from now.
  • Contemporaneous. Data captured at the time the activity happened, not reconstructed afterward.
  • Original. The first recording of an observation preserved rather than overwritten.
  • Accurate. Data that reflects what happened, free of undocumented correction.
  • Complete. Nothing missing: reprocessing, repeat testing, and all the surrounding context included.
  • Consistent. Records that align across systems, with no contradictions between the instrument log and the LIMS entry.
  • Available. Retrievable throughout the required retention period, whenever it’s requested.

Say each principle out loud and it sounds achievable. Prove all eight, across every instrument, workstation, share, and legacy system in a fragmented lab, and the picture gets harder fast.

The inspection-readiness checklist

Ahead of any inspection, four categories of evidence tend to come under the most scrutiny:

  1. Instrument inventory. A current, accurate record of every system generating regulated data, including the ones with no native audit trail.
  2. Data lifecycle evidence. Where data is created, how it moves, and where it’s stored, end to end.
  3. Audit-trail evidence. A record of who changed what and when, covering activity inside your validated applications and the changes that happen around them, such as a file edited directly in Windows.
  4. User-access evidence. Proof that access is controlled, attributable, and reviewed, with no shared logins masking who actually did the work.

Collect all four continuously and the checklist stops being something you assemble the week before an inspection, but rather something you already have.

For a deeper look at what inspectors expect and how to stay ready, download our latest white paper: Inspection Readiness Without the Chaos..

Chain of custody and e-signatures

Two threads run through nearly every ALCOA+ conversation with an inspector: chain of custody and electronic signatures.

Chain of custody is the traceable record of who touched a piece of data, in what order, from creation to archive. A single missing link, an unattributed edit, an undocumented handoff between systems, is often enough to trigger a follow-up question that turns into a finding.

Configurable electronic signatures close the other half of the gap. When sign-off is built into the workflow, approval, review, and release all carry a named, timestamped, attributable signature rather than a paper trail assembled after the fact. Compliance Builder supports both: real-time monitoring that builds the chain of custody as data moves, and electronic signatures configured to your process.

How continuous monitoring keeps the checklist answered

Most labs don’t fail an inspection because they’re non-compliant. They fail because the evidence of compliance is scattered: some of it in a validated application, some in a network share, some on an instrument that has never had an audit trail at all.

Picture an analyst who opens a results file directly in Windows, outside the instrument software, and corrects a value. The instrument’s own audit trail never sees it, because that trail only records what happens inside the application. To every validated system in the lab, the change is invisible.

Compliance Builder wraps around that fragmented environment and closes the gaps between your validated systems. It captures who did what and when across files, folders, databases, and instruments, including the changes that happen outside any application, so the audit trail is built continuously rather than reconstructed under pressure. Deletion protection guards against records being removed, whether by accident or on-purpose, and user tracking works even on shared or generic logins, so “who did this?” always has a named answer.

The result is a 21 CFR Part 11 checklist you can answer on any given day, not just the week an inspector is due. That’s the shift from reactive firefighting to continuous compliance: evidence that’s already there, so the inspection confirms control instead of testing whether you can find it in time.

The outcome

Fewer observations. Faster inspections. Confident submissions, because your team spent the quarter advancing the science instead of assembling proof after the fact.

Continuous monitoring won’t replace good process. It will de-risk the moment your process gets tested.

Ready to see how continuous monitoring closes the ALCOA+ gaps in your environment?

Request a demo to see real-time monitoring, audit trails, and configurable e-signatures in action.

.

L'équipe Instem

Instem est l'un des principaux fournisseurs de plateformes SaaS dans les domaines de la découverte, de la gestion des études, de la soumission réglementaire et de l'analyse des essais cliniques. Les applications d'Instem sont utilisées par des clients dans le monde entier, répondant aux besoins en pleine expansion des organisations des sciences de la vie et de la santé pour une prise de décision basée sur les données, conduisant à des produits plus sûrs et plus efficaces.

Partager cet article

Rester à jour

Recevez des conseils d'experts, des nouvelles de l'industrie et du contenu frais dans votre boîte de réception.